These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32404049)

  • 1. A prognostic nomogram for event-free survival in patients with atrial fibrillation before cardiac resynchronization therapy.
    Cai M; Hua W; Zhang N; Yang S; Hu Y; Gu M; Niu H; Zhang S
    BMC Cardiovasc Disord; 2020 May; 20(1):221. PubMed ID: 32404049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation incidence and impact of biventricular pacing on long-term outcome in patients with heart failure treated with cardiac resynchronization therapy.
    Jacobsson J; Reitan C; Carlson J; Borgquist R; Platonov PG
    BMC Cardiovasc Disord; 2019 Aug; 19(1):195. PubMed ID: 31409276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
    van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation burden and subsequent heart failure events in patients with cardiac resynchronization therapy devices.
    Tanawuttiwat T; Lande J; Smeets P; Gerritse B; Nazarian S; Guallar E; Cheng A
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1519-1526. PubMed ID: 32162753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of New-Onset Atrial Fibrillation in Patients Receiving CRT: Mechanistic Insights From Speckle Tracking Imaging.
    Sade LE; Atar I; Özin B; Yüce D; Müderrisoğlu H
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):99-111. PubMed ID: 26684972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a nomogram model for all-cause mortality risk in patients with chronic heart failure and atrial fibrillation.
    Guan L; Wang CH; Sun H; Sun ZJ
    BMC Geriatr; 2024 May; 24(1):470. PubMed ID: 38811919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial high-rate episodes predict clinical outcome in patients with cardiac resynchronization therapy.
    Jacobsson J; Platonov PG; Reitan C; Carlsson J; Borgquist R
    Scand Cardiovasc J; 2017 Apr; 51(2):74-81. PubMed ID: 27841021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine Learning Prediction of Response to Cardiac Resynchronization Therapy: Improvement Versus Current Guidelines.
    Feeny AK; Rickard J; Patel D; Toro S; Trulock KM; Park CJ; LaBarbera MA; Varma N; Niebauer MJ; Sinha S; Gorodeski EZ; Grimm RA; Ji X; Barnard J; Madabhushi A; Spragg DD; Chung MK
    Circ Arrhythm Electrophysiol; 2019 Jul; 12(7):e007316. PubMed ID: 31216884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram for predicting CRT response based on multi-parameter features.
    Lou Y; Hua Y; Yang J; Shi J; Jiang L; Yang Y
    BMC Cardiovasc Disord; 2024 Jul; 24(1):376. PubMed ID: 39030503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world behavior of CRT pacing using the AdaptivCRT algorithm on patient outcomes: Effect on mortality and atrial fibrillation incidence.
    Singh JP; Cha YM; Lunati M; Chung ES; Li S; Smeets P; O'Donnell D
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):825-833. PubMed ID: 32009263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymptomatic episodes of device-registered atrial tachyarrhythmia are not associated with worse cardiac resynchronization therapy response.
    Verbrugge FH; Nijst P; Van Herendael H; De Vusser P; Jacobs L; Vercammen J; Verhaert D; Vandervoort P; Dupont M; Mullens W; Rivero-Ayerza M
    Europace; 2014 Aug; 16(8):1197-204. PubMed ID: 24489074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel risk model for mortality and hospitalization following cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy: the alpha-score.
    Yang S; Liu Z; Hu Y; Jing R; Gu M; Niu H; Ding L; Xing A; Zhang S; Hua W
    BMC Cardiovasc Disord; 2020 Apr; 20(1):205. PubMed ID: 32345229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial.
    Botto GL; Boriani G; Favale S; Landolina M; Molon G; Tondo C; Biffi M; Grandinetti G; De Filippo P; Raciti G; Padeletti L
    Trials; 2011 Feb; 12():44. PubMed ID: 21324118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of long-term outcomes greater than 10 years after cardiac resynchronization therapy implantation.
    Patel D; Trulock KM; Moennich LA; Kiehl EL; Kumar A; Toro S; Donnellan E; Grimaldi A; Baranowski B; Hussein AA; Tarakji KG; Cantillon DJ; Niebauer M; Wazni OM; Varma N; Wilkoff BL; Rickard JW
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1182-1186. PubMed ID: 32108406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma tissue inhibitor of matrix metalloproteinase-1 a predictor of long-term mortality in patients treated with cardiac resynchronization therapy.
    Trucco E; Tolosana JM; Castel MÁ; Batlle M; Borràs R; Sitges M; Guash E; Matas M; Arbelo E; Berruezo A; Brugada J; Mont L
    Europace; 2016 Feb; 18(2):232-7. PubMed ID: 25883077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial.
    Kuck KH; Merkely B; Zahn R; Arentz T; Seidl K; Schlüter M; Tilz RR; Piorkowski C; Gellér L; Kleemann T; Hindricks G
    Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007731. PubMed ID: 31760819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy.
    Smit MD; Maass AH; Hillege HL; Wiesfeld AC; Van Veldhuisen DJ; Van Gelder IC
    Eur J Heart Fail; 2011 May; 13(5):543-50. PubMed ID: 21330294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy.
    Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C
    Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.